The level of women sexual hormones in patients with COPD (stage I-III)

G. A. Garagulya (Dniepropetrovsk, Ukraine)

Source: Annual Congress 2005 - COPD - pathogenesis II
Session: COPD - pathogenesis II
Session type: Thematic Poster Session
Number: 488
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. A. Garagulya (Dniepropetrovsk, Ukraine). The level of women sexual hormones in patients with COPD (stage I-III). Eur Respir J 2005; 26: Suppl. 49, 488

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The level of sexual hormones in postmenopausal women with COPD (stage I-II)
Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care
Year: 2008

The correlation between level of women sexual hormones and lung function parameters in patients with COPD
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008

The prevalence of low hemoglobin levels in patients with COPD stratified for disease stage
Source: Eur Respir J 2004; 24: Suppl. 48, 63s
Year: 2004

COPD in women: a particular phenotype
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019

Stage I lung cancer patients with or without symptoms – are the patients any different?
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020


Physician-diagnosed COPD GOLD stage IV in Östersund, Sweden: prevalence and patient characteristics
Source: Eur Respir J 2006; 28: Suppl. 50, 447s
Year: 2006

Prevalence of co-morbidities in Greek COPD patients in relation to the stage of the disease (COMPACT study)
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017


Comorbidities in stage IV COPD patients
Source: Annual Congress 2011 - COPD management
Year: 2011

Smoking and psychological status (PS) in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 151s
Year: 2004

High prevalence of osteoporosis in COPD patients independent of GOLD stage
Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010
Year: 2010


Sex related differences of lung cancer patients in relation to age, histology, stage, smoking habit and survival during the first year of the treatment
Source: Eur Respir J 2007; 30: Suppl. 51, 425s
Year: 2007

Frail patients with COPD (grade 2/group B) are at higher risk of falls than non-frail patients with the same disease severity
Source: International Congress 2019 – Insights into assessment of functional status in respiratory disease patients
Year: 2019

Is female gender a protective factor for NSCLC patients? A follow up study of 20 years of 478 patients
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011


COPD: Different psychology status (PS) in the patients with different co-morbidity rate
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011

Serum TGF-β level in patients with different stages of stable COPD
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008


Estrogenic hormonal function, age and development of OSAS in women
Source: Eur Respir J 2003; 22: Suppl. 45, 91s
Year: 2003

COPD: Different psychology status (PS) in patients with different cardiac co-morbidities rate
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012

Lung function evaluation and patients’ satisfaction with Elpenhaler® device in Greek COPD patients with =1 comorbidity versus patients without comorbidities-AEOLOS study.
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020


COPD patients with more severe GOLD stages have higher serum cystatin C levels
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012